Serum Institute of India, IAVI and Merck join forces to develop COVID-19 antibodies
News: Serum Institute of India(SII) and the International AIDS Vaccine Initiative (IAVI) have announced an agreement with pharmaceutical major Merck to develop SARS-CoV-2 neutralising monoclonal antibodies(mAbs). Facts: What are Monoclonal Antibodies? They …
Read More